1.65Open1.65Pre Close5 Volume0 Open Interest2.50Strike Price825.00Turnover364.27%IV2.52%PremiumJul 19, 2024Expiry Date1.63Intrinsic Value100Multiplier12DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type-0.8879Delta0.3317Gamma0.53Leverage Ratio-0.0041Theta-0.0006Rho-0.47Eff Leverage0.0003Vega
Eyenovia Stock Discussion
1 - Insider bought 1.5 million shares in July and paid 1 Million dollars
2 - Vanguard biggest institution in the world bought 5 million dollars for a call option
3 - First FDA MydCombi selling from April 2024, and they have a contract with Vision Source biggest Private Practice Optometrists in the USA and Canada. Vision Source multi a billion company.
4 - Second FDA's strongest eyedrop sales start the first of August an...
Eyenovia Inc - Requested Meeting With FDA to Discuss Validation of the Gen-2 Dispenser, Which We Anticipate Will Occur This Summer
Benzinga· 1 min ago
Company announces results from a Phase IV study of Mydcombi designed to characterize the efficacy and duration of the lowest deliverable dose (one 8μL spray per eye)
Also announces upcoming ARVO presentation on the unique technology behind clobetasol that allows for future ophthalmic suspensions to be dispensed with the O...
No comment yet